The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro Injections Reviews — UK Guide
Mounjaro (tirzepatide) is a prescription-only weight management injection that has generated significant interest among UK adults exploring medical weight loss options. Clinical trials and real-world feedback show mixed but generally positive results, with most users experiencing appetite reduction and weight loss alongside lifestyle changes. This guide reviews what Mounjaro actually does, what real experiences tell us, and whether it might be suitable for you based on NHS eligibility criteria and your personal health situation.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
What Clinical Data Shows About Mounjaro
The SURMOUNT-1 clinical trial, which tested Mounjaro's effectiveness, showed that participants lost an average of 20.9% of their body weight over 72 weeks when taking the maximum 15 mg dose alongside a reduced-calorie diet and increased physical activity. At the 10 mg dose, average weight loss was approximately 19.5%. However, results vary significantly between individuals — some users report clinically studied weight loss, whilst others achieve 25% or more.
- Key finding: Weight loss typically occurs gradually over 16–20 weeks as the dose increases from 2.5 mg to the target maintenance dose
- Appetite change: Most users report reduced hunger and feeling full more quickly, which helps support calorie reduction
- Sustainability: Weight loss is maintained whilst continuing the injection; stopping usually results in weight regain over time
These results are with concurrent lifestyle modification — Mounjaro is not a standalone solution without dietary and physical activity changes.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Real User Experience and Side Effects
User reviews consistently highlight that nausea is the most common initial experience, typically occurring in the first 1–2 weeks and often subsiding as the body adjusts. Other frequently reported side effects include constipation, diarrhoea, stomach discomfort, and reduced appetite (which many users view as beneficial for weight loss). The KwikPen injection itself is generally well-tolerated — most users report minimal injection site pain.
Critically, some users experience more persistent gastrointestinal issues that require dose adjustments or discontinuation. Energy levels and mood are highly individual — some feel energised by weight loss progress, whilst others report fatigue, particularly at higher doses. Use our free GLP-1 weight loss calculator to explore projected outcomes at different doses, which may help you discuss realistic expectations with your prescriber.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
What's the difference between Mounjaro and Wegovy?
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, whilst Wegovy (semaglutide) is a GLP-1 agonist only. Mounjaro clinical trials showed slightly higher average weight loss (~21% vs ~15%), but both are effective. The choice depends on your individual response and prescriber assessment. The KwikPen delivery method is identical for Mounjaro.
Can I get Mounjaro on the NHS in the UK?
Yes, Mounjaro (tirzepatide) has been approved by NICE for NHS use within specialist tier 3/4 weight management services. However, NHS access is limited, and waiting lists vary significantly by region. You can access Mounjaro privately through a UK-licensed prescriber following an online clinical assessment without an NHS referral.
How long does it take to see weight loss results from Mounjaro?
Most users begin noticing appetite reduction within 1–2 weeks of starting. Measurable weight loss typically appears within 4–6 weeks, but significant results (5%+ body weight) usually take 12–16 weeks as doses are gradually increased. Individual timelines vary based on starting weight, diet, activity level, and dose tolerance.
Who is eligible for Mounjaro in the UK?
UK adults with a BMI of 30 or above, or BMI of 27–29.9 with weight-related health conditions (such as type 2 diabetes, high blood pressure, or sleep apnoea), may be eligible. South Asian and Black African/Caribbean adults may qualify at slightly lower BMI thresholds. A clinical assessment by a prescriber is required to confirm suitability.
Are Mounjaro side effects permanent?
Most side effects are temporary and decrease as your body adjusts. Nausea typically resolves within 2–4 weeks. However, some gastrointestinal effects (constipation or diarrhoea) may persist, requiring dietary adjustments or dose modifications. Always report persistent side effects to your prescriber — dose reduction or switching may be appropriate.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.